Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.74 |
| ▸ | TSHR | P16473 | 1/20 | 0.74 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | MAOB | P27338 | 2/20 | 0.38 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.38 |
| ▸ | HDAC8 | Q9BY41 | 4/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.32 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.32 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.32 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.32 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.32 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.32 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.32 |
| ▸ | MAOA | P21397 | 1/20 | 0.32 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.32 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Styrene SCHEMBL8465847 | 0.86 | ALDH1A1 (1.00) | ALDH1A1TSHRTDP1TP53MAOB | |
| Styrene SCHEMBL140 | 0.86 | — | — | |
| Styrene SCHEMBL6258482 | 0.86 | ALDH1A1 (1.00) | ALDH1A1TSHRTDP1TP53MAOB | |
| Styrene SCHEMBL1226310 | 0.86 | ALDH1A1 (1.00) | ALDH1A1TSHRTDP1TP53MAOB | |
| Styrene SCHEMBL10892600 | 0.86 | ALDH1A1 (1.00) | ALDH1A1TSHRTDP1TP53MAOB | |
| Styrene SCHEMBL369036 | 0.86 | ALDH1A1 (1.00) | ALDH1A1TSHRTDP1TP53MAOB | |
| Styrene SCHEMBL9776790 | 0.86 | ALDH1A1 (1.00) | ALDH1A1TSHRTDP1TP53MAOB | |
| Styrene SCHEMBL4986035 | 0.86 | ALDH1A1 (1.00) | ALDH1A1TSHRTDP1TP53MAOB | |
| Styrene SCHEMBL11144289 | 0.86 | ALDH1A1 (1.00) | ALDH1A1TSHRTDP1TP53MAOB | |
| Styrene SCHEMBL8100955 | 0.86 | ALDH1A1 (1.00) | ALDH1A1TSHRTDP1TP53MAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101501080-B | Insulating layer, electronic component, field effect transistor, and polyvinylthiophenol | MITSUBISHI CHEM CORP | 2011-05-11 | — | — | CN | claimed |
| CN-101501080-A | Insulating layer, electronic component, field effect transistor, and polyvinylthiophenol | MITSUBISHI CHEM CORP (JP) | 2009-08-05 | — | — | CN | claimed |
| CN-109071529-A | pyrimidine compounds as JAK kinase inhibitors | 施万生物制药研发IP有限责任公司 | 2018-12-21 | — | — | CN | disclosed |
| CN-104114608-B | The manufacture method of polymerizable composition for optical material, its manufacture method and optical material | MITSUBISHI GAS CHEMICAL CO.,INC. (JP) | 2016-04-20 | — | — | CN | disclosed |
| CN-104114608-A | Polymerizable composition for optical material, method for producing same, and method for producing optical material | MITSUBISHI GAS CHEMICAL CO | 2014-10-22 | — | — | CN | disclosed |
| US-7943639-B2 | Such as 6-benzenesulfonyl-4-piperazin-1-yl-quinoline hydrochloride; for treatment of central nervous system and/or 5- HT6 receptor related disorders; for weight gain/loss | PROXIMAGEN LIMITED (GB) | 2011-05-17 | — | — | US | disclosed |
| CN-101501080-B | Insulating layer, electronic component, field effect transistor, and polyvinylthiophenol | MITSUBISHI CHEM CORP | 2011-05-11 | — | — | CN | disclosed |
| CN-101501080-A | Insulating layer, electronic component, field effect transistor, and polyvinylthiophenol | MITSUBISHI CHEM CORP (JP) | 2009-08-05 | — | — | CN | disclosed |
| CN-100472227-C | Light control plastic lens, coated sheet-like light control element for the lens production, and a production method for light control plastic lens | FUJI KASEI CO LTD (JP) | 2009-03-25 | — | — | CN | disclosed |
| EP-1897881-A2 | Compounds useful for the treatment of obesity, type II diabetes and CNS disorders | Biovitrum AB (publ) (SE) | 2008-03-12 | — | — | EP | disclosed |
| CN-101081845-A | Substituted sulphone and sulphonamide compounds useful for the treatment of obesity, type II diabetes and cns disorders | BIOVITRUM AB (SE) | 2007-12-05 | — | — | CN | disclosed |
| CN-1662521-A | Novel compounds useful for the treatment of obesity, type II diabetes and CNS disorders | BIOVITRUM AB (SE) | 2005-08-31 | — | — | CN | disclosed |
| CN-1657975-A | Light control plastic lens, coated sheet-like light control element for the lens production, and a production method for light control plastic lens | FUJI KASEI CO LTD (JP) | 2005-08-24 | — | — | CN | disclosed |
| EP-1513828-A1 | NEW COMPOUNDS USEFUL FOR THE TREATMENT OF OBESITY, TYPE II DIABETES AND CNS DISORDERS | Biovitrum AB (SE) | 2005-03-16 | — | — | EP | disclosed |
| US-20040024210-A1 | New compounds | PROXIMAGEN NEUROSCIENCE PLC (GB) | 2004-02-05 | — | — | US | disclosed |
| CN-1471645-A | Composition for optical material | 三菱瓦斯化学株式会社 | 2004-01-28 | — | — | CN | disclosed |
| WO-2004000828-A1 | NEW COMPOUNDS USEFUL FOR THE TREATMENT OF OBESITY, TYPE II DIABETES AND CNS DISORDERS | BIOVITRUM AB (SE) | 2003-12-31 | — | — | WO | disclosed |
| CN-1462290-A | Polymerization regulator and composition for resin | MITSUBISHI GAS CHEMICAL CO (JP) | 2003-12-17 | — | — | CN | disclosed |
| CN-1093145-C | Polymer polyol and flame retardant polyurethane resin and foam prepared therefrom | MITSUI CHEMICALS INC (JP) | 2002-10-23 | — | — | CN | disclosed |
| CN-1199059-A | Polymer polyol and flame retardant polyurethane resin and foam prepared therefrom | MITSUI CHEMICALS INC (JP) | 1998-11-18 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040024210-A1 | New compounds | SULT1E1, SULT2A1, SULT1A1 | ALDH1A1 705/4885TSHR 1379/4885TDP1 3728/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.